** Shares of Virpax Pharmaceuticals VRPX.O fall 10.4% to 50 cents premarket

** Late on Friday, co disclosed it had received notice on Nov. 19 from Nasdaq about non-compliance with independent director and audit committee rules

** Co says it has appointed Esha Randhawa as an independent director and audit committee member; adds that it has regained compliance with listing rule

** Plans to notify Nasdaq of its compliance - VRPX

** As of last close, stock had fallen 82.3% YTD

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))